Th1/Th17 cytokine signatures correlate with Crohn's disease activity in a 54?week cohort of patients treated with adalimumab. - de Castro-Martínez P; Guijarro LG; Monserrat J; Chaparro M; Guerra I; Iborra M; Cabriada JL; Bujanda L; Alba C; García-Sánchez V; Marín-Jiménez I; Barreiro-de Acosta M; et al. (Biomedicine & Pharmacotherapy, 2026)